Metformin modulates antioxidant and anti-inflammatory biomarkers in newly diagnosed patients with type 2 diabetes mellitus: an observational study
Journal of Basic and Clinical Physiology and Pharmacology · 2026
DOI: 10.1515/jbcpp-2025-0201 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2026. Verfasst von Saurav Misra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Kalpana Chawla Government Medical College, Karnal, Haryana, India. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Antioxidants, Hypoglycemic Agents. Die Arbeit nennt 65 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
Diabetes mellitus is a chronic metabolic condition marked by high blood sugar levels. As a primary treatment for type 2 diabetes (T2DM), metformin has demonstrated positive effects on antioxidant and anti-inflammatory biomarkers in newly diagnosed patients.
Methods
This was a prospective observational study. Blood samples were collected three times to analyse biomarkers. The study involved newly diagnosed T2DM patients who provided written informed consent. The assessments included plasma lipid peroxidation, superoxide dismutase (SOD), catalase, and Malondialdehyde (MDA) levels. Additionally, interleukin-6 (IL-6) was measured to evaluate inflammation.
Results
HbA1c levels significantly decreased at the 6-month follow-up. Analysis showed a reduction in SOD levels at each visit, with a statistically significant difference between the first and second follow-ups (p=0.03028). MDA levels also decreased at each visit, with a statistically significant difference between the first and second follow-ups (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Kalpana Chawla Government Medical College, Karnal, Haryana, India.
- Department of Pharmacology, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
- Multi-Disciplinary Research Unit, Kalpana Chawla Government Medical College, Karnal, Haryana, India.
- Department of Internal Medicine, Kalpana Chawla Government Medical College, Karnal, Haryana, India.
- Department of Biochemistry, Kalpana Chawla Government Medical College, Karnal, Haryana, India.
ORCID-Profile: Richa Goel
Zitieren
APA
Misra, S., Deb, T., Devi, S., Singh, A., & Goel, R. (2026). Metformin modulates antioxidant and anti-inflammatory biomarkers in newly diagnosed patients with type 2 diabetes mellitus: an observational study. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2025-0201
Vancouver
Misra S, Deb T, Devi S, Singh A, Goel R. Metformin modulates antioxidant and anti-inflammatory biomarkers in newly diagnosed patients with type 2 diabetes mellitus: an observational study. Journal of Basic and Clinical Physiology and Pharmacology. 2026. doi:10.1515/jbcpp-2025-0201
BibTeX
@article{Misra2026,
author = {Misra, Saurav and Deb, Tirthankar and Devi, Savita and Singh, Amandeep and Goel, Richa},
title = {Metformin modulates antioxidant and anti-inflammatory biomarkers in newly diagnosed patients with type 2 diabetes mellitus: an observational study},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2026},
doi = {10.1515/jbcpp-2025-0201}
}
EUVIMED